Home » Optimer Seeks Quick Green Light From FDA for Antibiotic Against Deadly Bug
Optimer Seeks Quick Green Light From FDA for Antibiotic Against Deadly Bug
San Diego-based Optimer Pharmaceuticals has spent more than $200 million and a dozen years of effort to get to the point where it can ask the FDA to clear its first product for sale on the U.S. market.
Xconomy
Xconomy
Upcoming Events
-
07May
-
14May
-
30May